These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23149169)

  • 41. Factors affecting smoking in schizophrenia.
    Beratis S; Katrivanou A; Gourzis P
    Compr Psychiatry; 2001; 42(5):393-402. PubMed ID: 11559866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.
    Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY
    Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years.
    John U; Meyer C; Rumpf HJ; Hapke U
    Drug Alcohol Depend; 2004 Dec; 76(3):287-95. PubMed ID: 15561479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
    Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
    Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.
    Zhang XY; Chen DC; Tan YL; Xiu MH; Cui J; Hui L; Yang FD; Kosten TR
    Psychopharmacology (Berl); 2014 Jan; 231(1):305-14. PubMed ID: 23963531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of Th17 cells in drug naïve, first episode schizophrenia.
    Ding M; Song X; Zhao J; Gao J; Li X; Yang G; Wang X; Harrington A; Fan X; Lv L
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():78-82. PubMed ID: 24447943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nicotine dependence in Croatian male inpatients with schizophrenia.
    Šagud M; Vuksan-Ćusa B; Jakšić N; Mihaljević-Peleš A; Živković M; Vlatković S; Prgić T; Marčinko D; Wang W
    BMC Psychiatry; 2018 Jan; 18(1):18. PubMed ID: 29357830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.
    Wei CW; Chen YQ; Ma M; Xiu MH; Zhang XY
    Transl Psychiatry; 2020 Jan; 10(1):18. PubMed ID: 32066717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study.
    Chen XJ; Wang DM; Zhou HX; Zhu RR; Tian Y; Du YX; Chen JJ; Chen DC; Wang L; Zhang XY
    Gen Hosp Psychiatry; 2021; 71():108-113. PubMed ID: 34000518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the Association Between Cigarette Smoking and Cognitive Performance in Patients With Schizophrenia-Spectrum Disorders: A Case-Control Study.
    Stramecki F; Kotowicz KD; Piotrowski P; Frydecka D; Rymaszewska J; Beszłej JA; Samochowiec J; Jabłoński M; Wroński M; Moustafa AA; Misiak B
    Front Psychiatry; 2018; 9():642. PubMed ID: 30559684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms.
    Good KP; Whitehorn D; Rui Q; Milliken H; Kopala LC
    Am J Psychiatry; 2006 May; 163(5):932-3. PubMed ID: 16648339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder.
    Patten CA; Gillin JC; Golshan S; Wolter TD; Rapaport M; Kelsoe J
    J Clin Psychiatry; 2001 May; 62(5):319-24. PubMed ID: 11411811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demographic, biochemical, clinical, and cognitive symptom differences between smokers and non-smokers in Chinese older male patients with chronic schizophrenia.
    Li W; Yue L; Xiao S
    Eur Arch Psychiatry Clin Neurosci; 2024 Mar; ():. PubMed ID: 38462585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia.
    Zhu R; Wang D; Wei G; Wang J; Zhou H; Xu H; Wang W; Wei S; Chen D; Xiu M; Wang L; Zhang XY
    Int J Psychiatry Clin Pract; 2021 Sep; 25(3):292-298. PubMed ID: 33879034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tobacco smoking and medical co-morbidities among patients with schizophrenia in a Nigerian clinical setting.
    Lasebikan VO
    Afr J Med Med Sci; 2014 Dec; 43(4):315-25. PubMed ID: 26234119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effort and cognition in schizophrenia patients.
    Gorissen M; Sanz JC; Schmand B
    Schizophr Res; 2005 Oct; 78(2-3):199-208. PubMed ID: 16154055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.